FSD Pharma Inc. announced this week it closed a deal to acquire Prismic Pharmaceuticals, a U.S.-based specialty pharmaceutical company dedicated to addressing the opioid crisis. Through the utilization of its micro-PEA platform, the company seeks to develop novel, non-addictive prescription drugs. Such formulations impact the endocannabinoid system. This means that lower doses of drugs can be used […]

CEO and Chairman of Emmaus Life Sciences, Dr. Yutaka Niihara, discusses expanding the application of pharmaceutical-grade L-glutamine (PGLG) as a therapeutic for sickle cell disease to investigating its potential in treating type II diabetes. Emmaus is set to conduct a clinical study in collaboration with the Straub Medical Center to explore the role of PGLG in […]

When Laika Kayani started to lose her voice late one night last year, she picked up her iPhone and got connected to a doctor through a video-chat service called American Well. Kayani, who works at a health-tech company in San Francisco, used the app because her young son and husband were asleep and there were no […]